Tao Huan, Yancey Patricia G, Blakemore John L, Zhang Youmin, Ding Lei, Jerome W Gray, Brown Jonathan D, Vickers Kasey C, Linton MacRae F
Department of Medicine, Atherosclerosis Research Unit, Division of Cardiovascular Medicine.
Department of Pathology, Microbiology and Immunology, and.
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI94229.
Autophagy modulates lipid turnover, cell survival, inflammation, and atherogenesis. Scavenger receptor class B type I (SR-BI) plays a crucial role in lysosome function. Here, we demonstrate that SR-BI regulates autophagy in atherosclerosis. SR-BI deletion attenuated lipid-induced expression of autophagy mediators in macrophages and atherosclerotic aortas. Consequently, SR-BI deletion resulted in 1.8- and 2.5-fold increases in foam cell formation and apoptosis, respectively, and increased oxidized LDL-induced inflammatory cytokine expression. Pharmacological activation of autophagy failed to reduce lipid content or apoptosis in Sr-b1-/- macrophages. SR-BI deletion reduced both basal and inducible levels of transcription factor EB (TFEB), a master regulator of autophagy, causing decreased expression of autophagy genes encoding VPS34 and Beclin-1. Notably, SR-BI regulated Tfeb expression by enhancing PPARα activation. Moreover, intracellular macrophage SR-BI localized to autophagosomes, where it formed cholesterol domains resulting in enhanced association of Barkor and recruitment of the VPS34-Beclin-1 complex. Thus, SR-BI deficiency led to lower VPS34 activity in macrophages and in atherosclerotic aortic tissues. Overexpression of Tfeb or Vps34 rescued the defective autophagy in Sr-b1-/- macrophages. Taken together, our results show that macrophage SR-BI regulates autophagy via Tfeb expression and recruitment of the VPS34-Beclin-1 complex, thus identifying previously unrecognized roles for SR-BI and potentially novel targets for the treatment of atherosclerosis.
自噬调节脂质周转、细胞存活、炎症和动脉粥样硬化的发生。I型清道夫受体B类(SR-BI)在溶酶体功能中起关键作用。在此,我们证明SR-BI在动脉粥样硬化中调节自噬。SR-BI缺失减弱了脂质诱导的巨噬细胞和动脉粥样硬化主动脉中自噬介质的表达。因此,SR-BI缺失分别导致泡沫细胞形成和凋亡增加1.8倍和2.5倍,并增加了氧化型低密度脂蛋白诱导的炎性细胞因子表达。自噬的药理学激活未能降低Sr-b1-/-巨噬细胞中的脂质含量或凋亡。SR-BI缺失降低了自噬的主要调节因子转录因子EB(TFEB)的基础水平和诱导水平,导致编码VPS34和Beclin-1的自噬基因表达降低。值得注意的是,SR-BI通过增强PPARα激活来调节Tfeb表达。此外,细胞内巨噬细胞SR-BI定位于自噬体,在那里它形成胆固醇结构域,导致Barkor的结合增强和VPS34-Beclin-1复合物的募集。因此,SR-BI缺乏导致巨噬细胞和动脉粥样硬化主动脉组织中VPS34活性降低。Tfeb或Vps34的过表达挽救了Sr-b1-/-巨噬细胞中缺陷的自噬。综上所述,我们的结果表明巨噬细胞SR-BI通过Tfeb表达和VPS34-Beclin-1复合物的募集来调节自噬,从而确定了SR-BI以前未被认识的作用以及动脉粥样硬化治疗的潜在新靶点。